Latest sweden
Is REvalMed facilitating or hindering orphan drug access in Spain?
Jake James, Analyst, investigates this further
TLV presents proposal to the Swedish government to facilitate pricing negotiations for new gene therapies
Jake James, Analyst, takes a look at the recent proposal by the TLV
